GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+14.87%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$341M
AUM Growth
+$341M
(+30%)
Cap. Flow
+$62.8M
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
70.61%
Holding
45
New
12
Increased
5
Reduced
12
Closed
5
Top Buys
| 1 |
DERM
Dermira, Inc.
DERM
|
$23.4M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$21.3M |
| 3 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$20.6M |
| 4 |
RXDX
Ignyta, Inc.
RXDX
|
$16M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$11.9M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$23.4M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
$6.64M |
| 3 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$5.82M |
| 4 |
Exelixis
EXEL
|
$5.44M |
| 5 |
Vericel Corp
VCEL
|
$4.18M |
Sector Composition
| 1 | Healthcare | 75.52% |
| 2 | Technology | 2.73% |
